As cited
Copy frozen at (site build).
regulatory
UK Panel Calls for Fresh Approach to Regulating Medical AI
A UK government commission recommended a life-cycle risk-based regulatory approach for artificial intelligence (AI)-enabled medical devices and healthcare software, rather than relying solely on premarket reviews. The commission found that one-time approval models are insufficient as these technologies continue to evolve over time.
Why it matters: Medical device manufacturers, healthcare providers, and regulators need to understand the shift toward continuous monitoring and post-market oversight of AI systems, which will affect product development timelines, compliance costs, and market authorization strategies in the UK and potentially influence international regulatory trends.
- First seen by Cybersecurity Tracker